Top Markets
Coin of the day
SomnoMed Limited SomnoMed Limited

SomnoMed Limited

SOM
Rang in Aktien #24937
SomnoMed Limited, together with its subsidiaries, produce and sells devices for... SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient’s mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient’s upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs, which are cleaning tablets to clean oral appliances. SomnoMed Limited was incorporated in 1987 and is headquartered in Crows Nest, Australia.
Aktienkurs
$0.2503761
Marktkapitalisierung
$55.02M
Veränderung (1 Tag)
-2.74%
Veränderung (1 Jahr)
-45.86%
Land
AU
Handel SomnoMed Limited (SOM)

Kategorie

P/B-Verhältnis für SomnoMed Limited (SOM)
P/B-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von SomnoMed Limited beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/B-Verhältnis bei 0.
P/B-Verlauf für SomnoMed Limited von 2026 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
3.7944 -
US
5.423 -
US
2.0146 -
IE
3.072 -
US
- -
DE